Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy
- 1 July 1994
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 29 (4) , 827-834
- https://doi.org/10.1016/0360-3016(94)90572-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Ultrasound-enhanced effects of adriamycin against murine tumorsUltrasound in Medicine & Biology, 1992
- Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomesInternational Journal of Cancer, 1992
- Pharmacokinetics and antitumor activity of epirubicin encapsulated in long‐circulating liposomes incorporating a polyethylene glycol‐derivatized phospholipidInternational Journal of Cancer, 1992
- Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissuesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1989
- Separation of liposome-associated doxorubicin from non-liposome-associated doxorubicin in human plasma: Implications for pharmacokinetic studiesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1989
- Flow Cytometric Analysis of Doxorubicin Accumulation in Cells From Human and Rodent Cell LinesJNCI Journal of the National Cancer Institute, 1989
- Toxicity of drug carriers to the mononuclear phagocyte systemAdvanced Drug Delivery Reviews, 1988
- Modulation of adriamycin transport by hyperthermia as measured by fluorescence-activated cell sortingCancer Chemotherapy and Pharmacology, 1987
- Clinical prospects for liposomesMedical Physics, 1982
- Design of Liposomes for Enhanced Local Release of Drugs by HyperthermiaScience, 1978